1.
Journal of Leukemia & Lymphoma
;
(12): 451-452, 2013.
Article
in Chinese
| WPRIM
| ID: wpr-474541
ABSTRACT
Multiple myeloma (MM) is a genetically complex disease that is becoming more common in today' s aging population.In the 18th European Hematology Association (EHA) annual meeting,there were a number of key topics focusing on the development of MM from intraclonal heterogeneity,novel therapeutic agents,and relapse and refractory MM therapy,etc.